Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Lindemans

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Annals of Clinical and Translational Neurology|May 22, 2023
Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophyMurtadha Al-Saady, Shanice Beerepoot, Bonnie C Plug, et al.
Blood|November 5, 2020
CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validationCoco de Koning, Susan Prockop, Ichelle van Roessel, et al.
Nature Immunology|March 22, 2016
Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host diseaseNathan D Mathewson, Robert Jenq, Anna V Mathew, et al.
Orphanet Journal of Rare Diseases|February 15, 2022
Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi)Daphne H Schoenmakers, Shanice Beerepoot, Sibren van den Berg, et al.
Nature Immunology|September 21, 2016
Corrigendum: Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host diseaseNathan D Mathewson, Robert Jenq, Anna V Mathew, et al.
Bone Marrow Transplantation|April 30, 2020
Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profileLotte E van der Wagen, Alberto Miranda-Bedate, Anke Janssen, et al.
Bone Marrow Transplantation|February 14, 2023
Outcome of haematopoietic cell transplantation in children with lysosomal acid lipase deficiency: a study on behalf of the EBMT Inborn Errors Working PartySu Han Lum, Milen Minkov, Simon A Jones, et al.
BMJ Open|June 4, 2024
An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocolRachel L Sagar, Eva Åström, Lyn S Chitty, et al.
Bone Marrow Transplantation|January 31, 2019
Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal studyMaheen Z Abidi, Parameswaran Hari, Min Chen, et al.
Journal of Human Immunity|July 9, 2026
TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMTGiulia Prunotto, Marie Parreillet, Bénédicte Neven, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Annals of Clinical and Translational Neurology|May 22, 2023
Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophyMurtadha Al-Saady, Shanice Beerepoot, Bonnie C Plug, et al.
Blood|November 5, 2020
CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validationCoco de Koning, Susan Prockop, Ichelle van Roessel, et al.
Nature Immunology|March 22, 2016
Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host diseaseNathan D Mathewson, Robert Jenq, Anna V Mathew, et al.
Orphanet Journal of Rare Diseases|February 15, 2022
Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi)Daphne H Schoenmakers, Shanice Beerepoot, Sibren van den Berg, et al.
Nature Immunology|September 21, 2016
Corrigendum: Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host diseaseNathan D Mathewson, Robert Jenq, Anna V Mathew, et al.
Bone Marrow Transplantation|April 30, 2020
Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profileLotte E van der Wagen, Alberto Miranda-Bedate, Anke Janssen, et al.
Bone Marrow Transplantation|February 14, 2023
Outcome of haematopoietic cell transplantation in children with lysosomal acid lipase deficiency: a study on behalf of the EBMT Inborn Errors Working PartySu Han Lum, Milen Minkov, Simon A Jones, et al.
BMJ Open|June 4, 2024
An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocolRachel L Sagar, Eva Åström, Lyn S Chitty, et al.
Bone Marrow Transplantation|January 31, 2019
Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal studyMaheen Z Abidi, Parameswaran Hari, Min Chen, et al.
Journal of Human Immunity|July 9, 2026
TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMTGiulia Prunotto, Marie Parreillet, Bénédicte Neven, et al.
Pageof 5